Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.

Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.

Item

http://www.wikidata.org/entity/Q35087495

Q35087495

about

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder Lurasidone for the Treatment of Irritability Associated with Autistic Disorder Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesi Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan.Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics.Participants' Voices From Within a Healthy Lifestyle Group.Meta-analysis of population-based studies comparing risk of cerebrovascular accident associated with first- and second-generation antipsychotic prescribing in dementia.Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Antipsychotic drug exposure and risk of myocardial infarction.Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.The burden of mood-disorder/cerebrovascular disease comorbidity: essential neurobiology, psychopharmacology, and physical activity interventions.Recovery from psychosis: physical health, antipsychotic medication and the daily dilemmas for mental health nurses.Cardiovascular Safety in Drug Development: A Role for Endothelial Function Tests.Risk of weight gain for specific antipsychotic drugs: a meta-analysis.Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders

P2860

Q28394341-25281C43-04A5-4055-AA52-BA6B420715ED Q33670588-2D70A8F7-93A0-42F5-80BC-B81A2A7FE728 Q33878816-3B3AF7C4-D8D2-4482-BAF5-844751E3ABAD Q35744928-A42E8D61-6BBA-4C95-A703-79276CFE5CA8 Q35754726-2B795BF6-2BC8-4647-BC67-05490B39C79C Q36118736-1C10BCB0-B3F4-4E60-810B-706E26D81CE7 Q36225284-51DF9DCF-830A-42CA-896F-9506D0376B0B Q36674291-D4B0DD73-492F-4E4E-B3FF-72F3652E3406 Q37015327-C5CDD615-B544-48EE-A27F-58F719D0AD57 Q37015355-6FC2C704-82D6-4A2A-9603-9B835D79AC37 Q38401379-E010520D-1044-463B-BAC5-887C2DC065C4 Q38599502-FD6C1A12-5E3E-4D9C-829D-78A109A5BF7A Q38785766-5B5ACF65-F346-4D5A-8E64-E2C51F70DF38 Q38819347-E7D3D0B7-C8C8-41EC-BB3C-F1588ECC3D90 Q38837641-5EF22220-CB10-4A29-815A-DAC737EAC657 Q38838870-EA94EB21-74C5-495C-A75D-2E7A88261733 Q38842714-AF350577-4DE2-4891-8C70-85ECC17D4811 Q39016420-FCA180D2-975E-4AB4-832F-199C26D45257 Q39353717-BB62B037-1A48-410A-87B9-1719482E0021 Q39417618-374463C3-646B-4F74-8EC0-D69691862CF9 Q48151550-4384983A-8D87-4C88-A797-E61B2D48D0E9 Q53139178-87F541B9-622E-4BCA-A9F6-76F3520CCF9A Q55513508-1F4B3F57-B5CC-44D3-A500-533049EA6019 Q58580517-D0AF3B13-03E1-416F-A652-3AD538E8B4FB

P2860

Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study.

Item

http://www.wikidata.org/entity/Q35087495

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu